Brief: Abeona Therapeutics Q3 EPS USD -0.48
13/11/2023 12:34
Nov 13 (Reuters) - Abeona Therapeutics Q3 net income USD -11.836 million. * Q3 income from operations USD -11.334 million * Q3 cash & investments USD 54.1 million * Q3 EPS USD -0.48
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports